A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?

1 hour ago 4

Robert Izquierdo, The Motley Fool

Sun, May 17, 2026 astatine 10:33 AM CDT 4 min read

Lynne N. Ward, Director astatine Merit Medical Systems (NASDAQ:MMSI), reported an open-market merchantability of 5,000 shares for a full of astir $313,000, according to the SEC Form 4 filing.

Transaction summary

Metric

Value

Shares sold (direct)

5,000

Transaction value

~$313,000

Post-transaction shares (direct)

7,809

Post-transaction worth (direct ownership)

~$489,000

Transaction and post-transaction worth based connected SEC Form 4 weighted mean acquisition terms ($62.61).

Key questions

  • How did the transaction impact Lynne Ward's ownership successful Merit Medical Systems?
    The merchantability reduced Ward's nonstop holdings by 39%, from 12,809 shares to 7,809 shares, with nary remaining indirect oregon derivative securities reported.

  • Were immoderate different forms of disposition, specified arsenic gifts oregon withholdings, progressive successful this filing?
    No; the filing strictly reflects a nonstop open-market sale, with nary gifts oregon shares withheld for taxes oregon administrative purposes.

  • What does the transaction size bespeak astir Ward's trading signifier and remaining capacity?
    The 5,000-share merchantability is the lone open-market merchantability successful the past 12 months and reflects a larger proportionality of Ward's shrinking disposable holdings, accordant with the ongoing simplification successful presumption size.

  • What continuing involvement does Ward person successful Merit Medical Systems pursuing this sale?
    Despite the reduction, Ward retains 7,809 shares of Common Stock (direct), maintaining a continuing ownership position.

Company overview

Metric

Value

Revenue (TTM)

$1.54 billion

Net income (TTM)

$139.34 million

Employees

7,400

1-year terms change

(36.06%)

* 1-year terms alteration calculated utilizing May 7, 2026 arsenic the notation date.

Company snapshot

  • Merit Medical Systems designs, manufactures, and markets single-use aesculapian products for interventional, diagnostic, and therapeutic procedures, with a absorption connected cardiology, radiology, oncology, captious care, and endoscopy.

  • It generates gross done the nonstop merchantability and organisation of proprietary aesculapian devices and customized procedural solutions to healthcare providers and OEM partners.

  • The institution serves hospitals, physicians, technicians, and nurses successful the United States and planetary markets done a operation of nonstop income and distributor relationships.

Merit Medical Systems, Inc. is simply a starring supplier of single-use aesculapian devices, operating astatine standard with implicit 7,400 employees and a planetary footprint. The company's strategy centers connected innovation successful minimally invasive procedures and procedural efficiency, supporting its competitory presumption successful the aesculapian instruments and supplies sector.

Read Entire Article